Phibro Animal Health | PAHC - 流动资产

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.06B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	流动资产	更改		日
Align Technology	USD 2.62B		82.47M	2025-12
ANI Pharmaceuticals	USD 753.12M		54.72M	2025-12
Assertio Holdings	USD 263.57M		53.36M	2025-09
Aurora Cannabis	CAD 445.84M		22M	2025-12
Bristol-Myers Squibb	USD 35.63B		2.41B	2025-09
Canopy Growth	CAD 524.67M		78.85M	2025-12
Corcept Therapeutics	USD 485.46M		55.67M	2025-12
Eli Lilly	USD 55.63B		6.44B	2025-12
Henry Schein	USD 4.46B		69M	2025-12
Idexx Laboratories	USD 1.41B		63.23M	2025-12
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Merck	USD 47.56B		10.49B	2025-09
Nektar Therapeutics	USD 281.36M		94.79M	2025-09
Pacira	USD 547.97M		14.78M	2025-12
Phibro Animal Health	USD 862.18M		26.39M	2025-12
Prestige Brands	USD 433.43M		63.98M	2025-12
Supernus Pharmaceuticals	USD 644.18M		50.29M	2025-12
Zoetis	USD 6.77B		185M	2025-12